Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy.

Brouwer J, Hooft L, Hoekstra OS, Riphagen II, Castelijns JA, de Bree R, Leemans CR.

Head Neck. 2008 Jul;30(7):889-97. doi: 10.1002/hed.20790. Review.

PMID:
18213716
2.

A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.

Pennant M, Takwoingi Y, Pennant L, Davenport C, Fry-Smith A, Eisinga A, Andronis L, Arvanitis T, Deeks J, Hyde C.

Health Technol Assess. 2010 Oct;14(50):1-103. doi: 10.3310/hta14500. Review.

3.

Which is the most reliable diagnostic modality for detecting locally residual or recurrent laryngeal squamous cell carcinoma after (chemo)radiotherapy?

Zbären P, de Bree R, Takes RP, Rinaldo A, Ferlito A.

Eur Arch Otorhinolaryngol. 2013 Nov;270(11):2787-91. doi: 10.1007/s00405-013-2564-3. Epub 2013 May 21. No abstract available.

PMID:
23689805
4.

Effectiveness of an (18)F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial.

de Bree R, van der Putten L, van Tinteren H, Wedman J, Oyen WJ, Janssen LM, van den Brekel MW, Comans EF, Pruim J, Takes RP, Hobbelink MG, Valdés Olmos R, van der Laan BF, Boers M, Hoekstra OS, Leemans CR.

Radiother Oncol. 2016 Feb;118(2):251-6. doi: 10.1016/j.radonc.2015.10.010. Epub 2015 Oct 20.

PMID:
26477395
5.

Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method.

Brouwer J, de Bree R, Comans EF, Akarriou M, Langendijk JA, Castelijns JA, Hoekstra OS, Leemans CR.

Radiother Oncol. 2008 May;87(2):217-20. doi: 10.1016/j.radonc.2008.02.001. Epub 2008 Mar 7.

PMID:
18329117
6.

Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging.

de Bree R, van der Putten L, Brouwer J, Castelijns JA, Hoekstra OS, Leemans CR.

Oral Oncol. 2009 Apr-May;45(4-5):386-93. doi: 10.1016/j.oraloncology.2008.10.015. Epub 2008 Dec 17. Review.

PMID:
19095487
7.

The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.

Brush J, Boyd K, Chappell F, Crawford F, Dozier M, Fenwick E, Glanville J, McIntosh H, Renehan A, Weller D, Dunlop M.

Health Technol Assess. 2011 Sep;15(35):1-192, iii-iv. doi: 10.3310/hta15350. Review.

8.

Evaluating PET-CT in the detection and management of recurrent cervical cancer: systematic reviews of diagnostic accuracy and subjective elicitation.

Meads C, Davenport C, Małysiak S, Kowalska M, Zapalska A, Guest P, Martin-Hirsch P, Borowiack E, Auguste P, Barton P, Roberts T, Khan K, Sundar S.

BJOG. 2014 Mar;121(4):398-407. doi: 10.1111/1471-0528.12488. Epub 2013 Dec 3. Review.

9.

The cost-effectiveness of 18FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy.

van Hooren AC, Brouwer J, de Bree R, Hoekstra OS, Leemans CR, Uyl-de Groot CA.

Eur Arch Otorhinolaryngol. 2009 Sep;266(9):1441-8. doi: 10.1007/s00405-008-0878-3. Epub 2008 Nov 29.

10.

Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement.

Brouwer J, Bodar EJ, De Bree R, Langendijk JA, Castelijns JA, Hoekstra OS, Leemans CR.

Eur Arch Otorhinolaryngol. 2004 Sep;261(8):417-22. Epub 2003 Nov 19.

PMID:
14625779
11.

FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review.

Liu T, Xu W, Yan WL, Ye M, Bai YR, Huang G.

Radiother Oncol. 2007 Dec;85(3):327-35. Epub 2007 Nov 26. Review.

PMID:
18037523
12.

2-Deoxy-2[F-18]FDG-PET for detection of recurrent laryngeal carcinoma after radiotherapy: interobserver variability in reporting.

van der Putten L, Hoekstra OS, de Bree R, Kuik DJ, Comans EF, Langendijk JA, Leemans CR.

Mol Imaging Biol. 2008 Sep;10(5):294-303. doi: 10.1007/s11307-008-0154-3. Epub 2008 Jul 12.

13.

FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis.

Pan L, Han Y, Sun X, Liu J, Gang H.

J Cancer Res Clin Oncol. 2010 Jul;136(7):1007-22. doi: 10.1007/s00432-009-0746-6. Epub 2010 Jan 21.

14.

A meta-analysis of 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancer.

Liu T, Cheng T, Xu W, Yan WL, Liu J, Yang HL.

Skeletal Radiol. 2011 May;40(5):523-31. doi: 10.1007/s00256-010-0963-8. Epub 2010 May 22. Review.

PMID:
20495798
15.

Recurrent thyroid cancer diagnosis: ROC study of the effect of a high-resolution head and neck 18F-FDG PET/CT scan.

Chatziioannou SN, Georgakopoulos AT, Pianou NK, Kafiri GT, Pavlou SN, Kallergi M.

Acad Radiol. 2014 Jan;21(1):58-63. doi: 10.1016/j.acra.2013.09.017.

PMID:
24331265
16.

Dual time point 18FDG-PET/CT versus single time point 18FDG-PET/CT for the differential diagnosis of pulmonary nodules: a meta-analysis.

Zhang L, Wang Y, Lei J, Tian J, Zhai Y.

Acta Radiol. 2013 Sep;54(7):770-7. doi: 10.1177/0284185113481594. Epub 2013 Apr 30.

PMID:
23528566
17.
18.

Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.

Guo H, Zhu H, Xi Y, Zhang B, Li L, Huang Y, Zhang J, Fu Z, Yang G, Yuan S, Yu J.

J Nucl Med. 2007 Aug;48(8):1251-8. Epub 2007 Jul 13.

19.
20.

Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers.

Tshering Vogel DW, Zbaeren P, Geretschlaeger A, Vermathen P, De Keyzer F, Thoeny HC.

Eur Radiol. 2013 Feb;23(2):562-9. doi: 10.1007/s00330-012-2596-x. Epub 2012 Aug 4.

Supplemental Content

Support Center